| Authors: |
van der Veen B; Boehringer Ingelheim Pharma GmbH & Co. KG, Neuroscience & Mental Health Disease Research, Biberach an der Riss, Germany. Bastiaan.van_der_veen@boehringer-ingelheim.com., Ionescu TM; Boehringer Ingelheim Pharma GmbH & Co. KG, Neuroscience & Mental Health Disease Research, Biberach an der Riss, Germany., Deiana S; Boehringer Ingelheim Pharma GmbH & Co. KG, Neuroscience & Mental Health Disease Research, Biberach an der Riss, Germany., Nissen W; Boehringer Ingelheim Pharma GmbH & Co. KG, Neuroscience & Mental Health Disease Research, Biberach an der Riss, Germany., Wotjak CT; Boehringer Ingelheim Pharma GmbH & Co. KG, Neuroscience & Mental Health Disease Research, Biberach an der Riss, Germany., du Hoffmann J; Boehringer Ingelheim Pharma GmbH & Co. KG, Neuroscience & Mental Health Disease Research, Biberach an der Riss, Germany. |